ProKidney Corp expected to post a loss of 16 cents a share - Earnings Preview

Prokidney

04/11/2023 03:09

* ProKidney Corp  PROK.OQ   PROK.O  is expected to show no
change
in quarterly revenue when it reports  results 
    * 
    * ​Refinitiv's mean analyst estimate for ProKidney Corp is
for a
loss of 16 cents per share. 
    * The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 5 "strong buy" or
"buy," 1 "hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for ProKidney
Corp is
$15​, above​ its last closing price of $1.61. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Jun. 30 2023  -0.32       -0.39      -0.14     Beat    64.4
 Mar. 31 2023  -0.25       -0.39      -0.16     Beat    59.1
 Dec. 31 2022  -0.24       -0.25      -0.11     Beat    55.1​
 Sep. 30 2022  -0.06       -0.24      -0.13     Beat    44.8
 ​​                                                     
                                                        ​
 This summary was machine generated November 4 at 03:09 GMT.  All
figures in US dollars  unless otherwise stated